lobbying_activities: 3801545

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3801545	0679ee05-1eb5-486c-a340-9629c2e096db	Q1	WILLOW LABORATORIES	401109834	WILLOW LABORATORIES	2026	first_quarter	HCR	Support for coverage and reimbursement for diabetes prevention and wellness technologies; patient safety; support for PBM reform and corporate governance.	HOUSE OF REPRESENTATIVES,SENATE			0	0	2026-04-01T09:40:16-04:00